Screener
Bausch Health Companies BHC Bausch + Lomb — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | Three Months Ended March 31, / Salix / 2026 | Three Months Ended March 31, / Salix / 2025 | Three Months Ended March 31, / International / 2026 | Three Months Ended March 31, / International / 2025 | Three Months Ended March 31, / Solta Medical / 2026 | Three Months Ended March 31, / Solta Medical / 2025 | Three Months Ended March 31, / Diversified / 2026 | Three Months Ended March 31, / Diversified / 2025 | Three Months Ended March 31, / Bausch + Lomb / 2026 | Three Months Ended March 31, / Bausch + Lomb / 2025 | Three Months Ended March 31, / Total / 2026 | Total / 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | $639 | $542 | $285 | $262 | $171 | $113 | $185 | $205 | $1,244 | $1,137 | $2,524 | $2,259 |
| Less: | ||||||||||||
| Cost of goods sold (a) | 47 | 43 | 112 | 102 | 53 | 27 | 27 | 30 | 482 | 481 | ||
| Cost of other revenues | — | — | 16 | 17 | — | — | — | — | 1 | 1 | ||
| Selling, general and administrative | 105 | 111 | 63 | 52 | 35 | 28 | 43 | 45 | 439 | 447 | ||
| Research and development | 19 | 17 | 6 | 6 | 8 | 5 | 3 | 3 | 45 | 28 | ||
| Segment profit | $468 | $371 | $88 | $85 | $75 | $53 | $112 | $127 | $277 | $180 | $1,020 | $816 |
| Corporate | (258) | (268) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's bausch + lomb — revenue?
- Bausch Health Companies (BHC) reported bausch + lomb — revenue of $1.24B in Q1 2026.
- How has Bausch Health Companies's bausch + lomb — revenue changed year-over-year?
- Bausch Health Companies's bausch + lomb — revenue increased by 9.4% year-over-year, from $1.14B to $1.24B.
- What is the long-term trend for Bausch Health Companies's bausch + lomb — revenue?
- Over 4 years (2021 to 2025), Bausch Health Companies's bausch + lomb — revenue has grown at a 7.9% compound annual growth rate (CAGR), from $3.77B to $5.1B.
- What does bausch + lomb — revenue mean?
- Represents the total gross income generated from the sale of goods and services within the Bausch + Lomb segment, excluding applicable taxes. This is the primary indicator of the segment's market demand, pricing power, and overall commercial success.
Ask your AI about Bausch Health Companies's bausch + lomb — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude